{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:00:34Z","timestamp":1760709634671},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ijrobp.2018.05.078","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T12:39:32Z","timestamp":1528375172000},"page":"508-514","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)"],"prefix":"10.1016","volume":"102","author":[{"given":"Bouthaina Shbib","family":"Dabaja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Specht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.05.078_bib1","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: Evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib2","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2648::AID-CNCR22>3.0.CO;2-R","article-title":"B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology","volume":"85","author":"Soslow","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib3","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","article-title":"Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: A high-risk subtype","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib4","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia","volume":"99","author":"Hoelzer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12185-014-1585-z","article-title":"Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: Long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols","volume":"99","author":"Kobayashi","year":"2014","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","article-title":"Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"18","author":"Kantarjian","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib7","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1002\/cncr.25354","article-title":"Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration","volume":"116","author":"Kantarjian","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/leu.2013.312","article-title":"The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience","volume":"28","author":"Jain","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib9","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3109\/10428194.2013.828350","article-title":"Long-term outcomes of modified Berlin-Frankfurt-Munster-90 regimen in adults with T-lymphoblastic lymphoma: A single-center experience","volume":"55","author":"Wang","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib10","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/cncr.10552","article-title":"The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma","volume":"94","author":"Dabaja","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3109\/0284186X.2014.889850","article-title":"Treatment outcome in T-cell lymphoblastic lymphoma in adults\u2014a population-based study from the Swedish Lymphoma Registry","volume":"53","author":"Ellin","year":"2014","journal-title":"Acta Oncologica"},{"issue":"2 Suppl","key":"10.1016\/j.ijrobp.2018.05.078_bib12","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.ijrobp.2016.06.416","article-title":"Effectiveness of radiation treatment in adult patients with mediastinal T cell lymphoblastic leukemia\/lymphoma (abstract 1003)","volume":"96","author":"Abou Yehia","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JCO.2015.61.5385","article-title":"Pediatric-like acute lymphoblastic leukemia therapy in adults with lymphoblastic lymphoma: The GRAALL-LYSA LL03 Study","volume":"34","author":"Lepretre","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib14","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1002\/cncr.23979","volume":"113","author":"Arakelyan","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00277-011-1252-x","article-title":"Results of a lymphoblastic leukemia-like chemotherapy program with risk adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma","volume":"91","author":"Cortelazzo","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.V124.21.370.370","article-title":"Favorable outcome in a large cohort of prospectively treated adult patients with T-lymphoblastic lymphoma (T-LBL) despite slowly evolving complete remission assessed by conventional radiography","volume":"124","author":"G\u00f6kbuget","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib17","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin's lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1748-717X-9-94","article-title":"Dosimetric advantages of a \u201cbutterfly\u201d technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma","volume":"9","author":"Voong","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ijrobp.2009.11.013","article-title":"Radiation for Hodgkin's lymphoma in young female patients: A new technique to avoid the breasts and decrease the dose to the heart","volume":"79","author":"Dabaja","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: Field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","article-title":"Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer","volume":"79","author":"Feng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijrobp.2015.02.010","article-title":"Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma","volume":"92","author":"Pinnix","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.078_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1748-717X-7-186","article-title":"Different IMRT solutions versus 3D-conformal radiation therapy in early stage Hodgkin lymphoma: Dosimetric comparison and clinical considerations","volume":"7","author":"Fiandra","year":"2012","journal-title":"Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618309313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618309313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T01:56:20Z","timestamp":1571450180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618309313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0360301618309313"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.05.078","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.05.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}